Cytomedix Inc. announced that David E. Jorden has been appointed as Executive Chairman of the company's Board of Directors. Mr. Jorden has served on the company's Board since September 2008 and will replace Acting Chairman of the Board, James Benson, who will remain on the company's Board and as its Principal Director. David Jorden, age 49, has a broad business background in finance and investing. From 2003 to 2008 he was a Vice President with Morgan Stanley's Private Wealth Management group, where he was responsible for equity portfolio management for high net worth individuals.